🚀 SPACE & DRONE STOCKS — DEEP DIVE RESEARCH REPORT

Top 10 Space + Top 10 Drone Picks for 2026

Apex Research | May 28, 2026 | All data live-fetched this session via yfinance + web

> For Bill — You're +68% YTD. This is not a "hold forever" list. These are setups, catalysts, and thesis calls for a swing trader who wants edge. Numbers are live. Opinions are direct. No filler.

PRE-FLIGHT CHECKS — What Got Excluded & Why

Space universe reviewed: RKLB, ASTS, PL, SPCE, MNTS, LMT, NOC, RTX, BA, BWXT, KTOS, HII, GD, SATL, VORB, ASTR, IRDM, VSAT, GSAT, SPIR, RDW

Eliminated:

• SPCE (Virgin Galactic) — Revenue $1.3M, -50.8% rev growth, $246M EBITDA burn, 22.6% short interest. Dead money.
• VORB, ASTR — Delisted. Gone.
• MNTS (Momentus) — $173M mkt cap, $4M TTM revenue, no analyst coverage. Science project.
• VSAT — $85.63, up 10x from 52w low but only +3% revenue growth at $4.6B revenue. Post-restructuring story, borderline.
• SPIR (Spire Global) — Revenue -33.7% YoY, high short interest (12.3%). Execution problems.
• IRDM (Iridium) — Profitable, 71.5% gross margin, $438M EBITDA, but only 1.9% revenue growth and price at $51.36 already well above analyst target of $36.38. Priced for perfection on a slow-growth story.
• HII — Good company, 13.4% rev growth, but deeply in the shipbuilding/defense bucket, limited pure-space thesis.
• BA, LMT — Drone section only / honorable mention.

Drone universe reviewed: AVAV, JOBY, ACHR, LILM, UAVS, RCAT, DPRO, KTOS, AXON, AEYE, EDBL, DPRO, SKYD

Eliminated:

• SKYD — Delisted.
• LILM (Lilium) — Bankrupt/delisted. The relaunched entity has no US listing.
• AEYE — This is AudioEye (web accessibility software). Not a drone company. Incorrectly flagged.
• UAVS (AgEagle) — Revenue declining -61.6%, $72M mkt cap, no analyst target. Dead.
• EDBL — No liquid data; too small/illiquid for a swing trader.

🚀 SPACE STOCKS — TOP 10 FOR 2026

#1 — RKLB: Rocket Lab USA

Price: $145.84 | Mkt Cap: $84.4B | 52w Range: $25.24 — $151.00

Revenue (TTM): $679.6M | Rev Growth (TTM): +63.5% | Gross Margin: 36.6%

P/S Ratio: 124.2x | Analyst Target: $103.91 (-28.8% from current) | Rec: Buy (18 analysts)

EBITDA: -$164.8M | Short Interest: 5.8%

Why It's In The Top 10:

Rocket Lab is the only pure-play publicly-traded launch company with an operational rocket (Electron, 60+ launches), a growing spacecraft manufacturing division, and a next-gen medium rocket (Neutron) in development. In the last 30 days alone: $90M Space Force contract for GEO satellites, $30M HASTE hypersonic contract with Anduril, Motiv Space Systems acquisition (Mars robotics), and the biggest booking in company history for multiple Neutron launches. This is a company building the full-stack space infrastructure business.

Key Catalysts:

• Neutron rocket first launch targeting 2026 — if successful, opens $10B+ medium-class launch market
• $90M Space Force satellite contract (May 22, 2026) adds to $1B+ backlog trajectory
• Motiv Space Systems acquisition adds Mars-proven robotics IP for in-space servicing
• RKLB/Raytheon teaming on Space-Based Interceptor program — SDI money incoming
• Revenue forecast $934M for FY2026 (consensus) = +55% YoY growth

Key Risks:

• Trading at $145.84 vs analyst consensus target of $103.91 — stock has massively outrun analyst models. Highest analyst target is $150 (barely above current).
• EBITDA still negative at -$164.8M. Not profitable yet.
• Neutron delays would crush sentiment. Any technical issue = 20-30% drawdown.
• P/S of 124x prices in years of perfect execution.

Apex Verdict: The premier space pure-play on the planet. Trading above all analyst targets — swing traders: only buy dips into $120-130 range; don't chase at $145+. Long-term, this is the SpaceX analog for public market investors.

#2 — ASTS: AST SpaceMobile

Price: $126.37 | Mkt Cap: $49.0B | 52w Range: $22.47 — $131.20

Revenue (TTM): $84.9M | Rev Growth (TTM): +1,952% (from $4.1M base) | Gross Margin: 44.8%

P/S Ratio: 577x | Analyst Target: $83.47 (-33.7% from current) | Rec: Hold (consensus), but 3 Strong Buy

EBITDA: -$316.4M | Short Interest: 17.6%

Why It's In The Top 10:

ASTS is the most disruptive thesis in telecom/space: replace cell towers with satellites. Their BlueBird constellation connects standard smartphones directly to space broadband — no special hardware. Partnership with AT&T, Verizon, Vodafone, and Rakuten. If this works at scale, the TAM is every unconnected human on earth. FY2026 revenue forecast of $180M growing to $830M in FY2027 as more BlueBird satellites come online.

Key Catalysts:

• BlueBird commercial service launched, AT&T/Verizon subscriber revenue now flowing
• FY2027 analyst consensus: $830M revenue (361% growth from FY2026E) as constellation scales
• Only publicly-traded direct-to-device satellite company at scale
• Government/defense contracts possible given military communications use-case

Key Risks:

• 17.6% short interest — significant skeptic camp with real arguments
• Analyst target of $83.47 vs current $126.37 = priced for flawless execution through 2027
• Satellite production bottlenecks could delay capacity ramp
• SpaceX Starlink direct-to-cell is a direct competitor with deeper pockets
• EBITDA burn of -$316M will require capital raises (dilution risk)

Apex Verdict: Highest-risk, highest-reward space thesis on this list. Speculative bet with real revenue traction. For swing traders: 17.6% short interest creates violent squeeze/capitulation swings — trade the range ($90-$131), don't hold through satellite deployment updates blind.

#3 — BWXT: BWX Technologies

Price: $198.11 | Mkt Cap: $18.1B | 52w Range: $123.12 — $241.82

Revenue (TTM): $3.38B | Rev Growth (TTM): +26.1% | Gross Margin: 22.7%

P/S Ratio: 5.4x | Analyst Target: $239.27 (+20.8% upside) | Rec: Buy (14 analysts)

EBITDA: $464.6M | Short Interest: 4.0%

Why It's In The Top 10:

BWXT is the most overlooked nuclear infrastructure stock that touches space. They build nuclear reactors for the US Navy (every submarine and carrier), AND they're the primary contractor for NASA's Space Nuclear Propulsion program — developing the nuclear thermal rocket engine that will cut Mars transit from 9 months to ~4 months. Revenue is real, profitable ($464M EBITDA), growing at 26%, and Deutsche Bank just upgraded on May 15 from Buy to Buy with target raised to $255. This is a cash-generating defense/space business, not a spec play.

Key Catalysts:

• NASA nuclear thermal propulsion contract ramp — Artemis-era hardware
• DoD nuclear microreactor contracts (Project Pele completed, follow-on work)
• Revenue forecast accelerating as naval nuclear backlog converts
• Deutsche Bank upgrade May 15, 2026 — target raised to $255
• Down 18% from 52w high ($241.82) — still in buy-the-dip territory

Key Risks:

• P/E of 53x — not cheap on earnings basis despite real profitability
• Political risk: any nuclear policy reversal could slow space propulsion contracts
• One strong sell analyst outlier — worth monitoring
• M&A risk: BWXT is a potential acquisition target (premium would be good, uncertainty is not)

Apex Verdict: Best risk-adjusted space pick on this list. Profitable, growing, backed by defense spending tailwinds, and 20% to analyst target. Growth compounder with real cash flow. Bill's size: this is a core hold, not a lottery ticket.

#4 — KTOS: Kratos Defense & Security Solutions

Price: $64.09 | Mkt Cap: $12.0B | 52w Range: $35.88 — $134.00

Revenue (TTM): $1.42B | Rev Growth (TTM): +22.6% | Gross Margin: 22.9%

P/S Ratio: 8.5x | Analyst Target: $113.05 (+76.4% upside) | Rec: Buy (20 analysts)

EBITDA: $81.2M | Short Interest: 8.0%

Why It's In The Top 10:

Kratos is the Pentagon's leading developer of low-cost, attritable UAVs (XQ-58A Valkyrie loyal wingman, UTAP-22 Mako), rocket propulsion, satellite communications, and hypersonic targets. With $1.42B in TTM revenue growing at 22.6%, profitable (EBITDA+), and trading at a 76% discount to analyst consensus target of $113 — KTOS is both a space and drone name. The DoD is aggressively shifting from expensive legacy platforms to cheap-attritable swarms. KTOS builds those swarms.

Key Catalysts:

• XQ-58A Valkyrie Collaborative Combat Aircraft program — $1B+ award potential in 2026
• Revenue forecast $1.78B for FY2026 (+31.9% YoY) — FY2027 $2.2B
• Rocket propulsion division winning NASA and Space Force propulsion contracts
• Defense budget tailwinds: NDAA FY2026 prioritizes drone warfare and autonomous systems
• 20 analysts covering, 12 strong buy — significant institutional conviction

Key Risks:

• Down 52% from 52w high of $134 — means something went wrong. Q1 2026 results disappointed on margins.
• Gross margins thin at 22.9% — cost overruns on fixed-price contracts are a persistent risk
• Competition from Anduril, Shield AI (both private) for USAF contracts

Apex Verdict: The best value play in defense drones/space at current levels. 76% upside to consensus target on a profitable, fast-growing defense name — this is a strong buy on weakness. Appears in BOTH top 10 lists because it genuinely spans both sectors.

#5 — NOC: Northrop Grumman

Price: $551.64 | Mkt Cap: $78.4B | 52w Range: $468.50 — $774.00

Revenue (TTM): $42.4B | Rev Growth (TTM): +4.4% | Gross Margin: 20.5%

P/S Ratio: 1.85x | Analyst Target: $696.95 (+26.3% upside) | Rec: Buy

EBITDA: $7.31B | Short Interest: 1.2% (low — institutions love it)

Why It's In The Top 10:

Northrop is the deepest space company among the defense primes. They build the B-21 Raider (next-gen bomber), James Webb Space Telescope (delivered), the GBSD/Sentinel ICBM system, and classified satellite programs you'll never read about. At 1.85x P/S with $7.3B EBITDA and trading 26% below analyst target — this is deep value for the sector. The stock is down 28.8% from its 52w high of $774. Space budget is only going up.

Key Catalysts:

• GBSD (Ground-Based Strategic Deterrent) / Sentinel ICBM program — $100B+ over lifetime
• Space Systems division growing (classified + commercial satellites)
• Geopolitical spending cycle: NATO 2% GDP pledges, AUKUS, Indo-Pacific buildup
• 26% upside to analyst consensus target of $696.95
• Low short interest (1.2%) = no squeeze risk, steady institutional ownership

Key Risks:

• Revenue growth at only 4.4% TTM — this is a slow-and-steady story, not a momentum trade
• Cost overruns on B-21 program have been a recurring headache
• Trading at P/E of 17.3x which is actually reasonable but priced as a value stock

Apex Verdict: The "sleep at night" space stock. 26% upside to consensus, profitable, low risk. If you want space exposure without volatility, NOC at $550 is a gift. For a swing trader: buy on dips toward $520, target $650+.

#6 — RTX: RTX Corporation (Raytheon Technologies)

Price: $176.97 | Mkt Cap: $238.3B | 52w Range: $131.90 — $214.50

Revenue (TTM): $90.4B | Rev Growth (TTM): +8.7% | Gross Margin: 20.2%

P/S Ratio: 2.64x | Analyst Target: $215.27 (+21.6% upside) | Rec: Buy

EBITDA: $15.3B | Short Interest: 1.1%

Why It's In The Top 10:

RTX is $90B in revenue and still growing at 8.7%. Collins Aerospace makes satellite systems, space optics, and space vehicles. Raytheon makes SM-3/SM-6 missiles (space intercept layer), hypersonic defense systems, and is now partnered with Rocket Lab on Space-Based Interceptor demonstration (May 2026). The GTF engine recall is largely behind them. Trading at a 17% discount from 52w high with 22% upside to target.

Key Catalysts:

• Space-Based Interceptor program with RKLB — potentially massive if SDI spending accelerates
• Collins Aerospace landing on multiple Artemis supply contracts
• Pratt & Whitney GTF engine recall charges winding down — margins recovering
• Raytheon counter-drone systems (Coyote, Ku-band interceptors) = dual space/drone revenue

Key Risks:

• Massive company — alpha is harder to extract vs smaller names
• GTF engine program still carries tail risk on replacement costs
• Growth at 8.7% is good for the size, but won't excite momentum traders

Apex Verdict: Defensive space + counter-drone play with real upside. Best large-cap name on this list if you want safety + 21% upside. For Bill: RTX is a core portfolio anchor, not a swing trade.

#7 — PL: Planet Labs PBC

Price: $48.58 | Mkt Cap: $17.3B | 52w Range: $3.66 — $51.13

Revenue (TTM): $307.7M | Rev Growth (TTM): +41.1% | Gross Margin: 56.2%

P/S Ratio: 56.3x | Analyst Target: $35.50 (-27.1% from current) | Rec: Buy (7 Strong Buy, 3 Hold, 1 Strong Sell)

EBITDA: -$45.0M | Short Interest: 11.4%

Why It's In The Top 10:

Planet Labs has the world's largest Earth observation satellite constellation (200+ Dove satellites + SkySat). They're transitioning from raw imagery to AI-powered geospatial analytics — "data as a service" model with 56% gross margins. Revenue up 41% with a pathway to EBITDA profitability. Wedbush raised target to $50 (May 14), Goldman has $20 target (the skeptic). The stock went from $3.66 to $51 in 12 months. Momentum is real.

Key Catalysts:

• Wedbush raised target to $50 (May 14, 2026) — near current price
• AI geospatial analytics contracts with DoD Intelligence Community growing
• 56% gross margins with improving EBITDA trend — approaching breakeven
• Ukraine/Taiwan conflicts driving global demand for real-time satellite imagery
• 41.1% revenue growth with improving unit economics as constellation is fully deployed

Key Risks:

• Analyst consensus target $35.50 vs price $48.58 — stock is trading 27% above the average target
• 11.4% short interest — shorts argue it's massively overvalued on fundamentals
• Google, Maxar (Maxar acquired), and Airbus have competing constellation assets
• EBITDA still negative

Apex Verdict: Momentum + AI narrative driving this above fundamentals. For swing traders: watch for the $40-42 support level as a re-entry. The AI-geospatial story is real, but the current price has run ahead of targets. Wedbush's $50 ceiling is essentially current price — limited near-term upside.

#8 — GSAT: Globalstar

Price: $84.30 | Mkt Cap: $10.9B | 52w Range: $17.91 — $84.67

Revenue (TTM): $283.0M | Rev Growth (TTM): +16.7% | Gross Margin: 63.7%

P/S Ratio: 38.4x | Analyst Target: $90.00 (+6.8% upside — only 3 analysts) | Rec: Buy

EBITDA: $109.2M | Short Interest: 6.5%

Why It's In The Top 10:

Globalstar is the Apple satellite story. Apple integrated Globalstar's network for Emergency SOS via Satellite (all iPhone 14/15/16+ worldwide) and paid for a significant constellation upgrade. This is essentially Apple's satellite infrastructure arm, with recurring revenue from a customer who has zero incentive to find a replacement. The stock went from $17.91 to $84.67 — a near 5x in 12 months. It's now at its 52w high with very thin analyst coverage (only 3 analysts).

Key Catalysts:

• Apple Emergency SOS subscription revenues now fully flowing globally
• Potential Apple Watch satellite connectivity expansion (rumored)
• New constellation satellites being deployed — capacity expansion
• EBITDA positive ($109M) and growing at 16.7% revenue growth

Key Risks:

• Trading at 52-WEEK HIGH right now — this is not a buy here; wait for pullback
• Only 3 analysts covering it — very thin coverage means price discovery is distorted
• P/S of 38.4x on a $283M revenue company is stretched
• Apple concentration risk: if Apple moves to Starlink or its own system, GSAT is in trouble
• Analyst target only $90 (just 6.8% above current) — analysts don't see much more upside

Apex Verdict: Exceptional story already priced in at 52w high. Don't buy today. Wait for a pullback to $65-70 range, or wait for a positive Apple hardware event (iPhone 17 cycle) as a catalyst. Event-driven trade — not a hold-forever position.

#9 — RDW: Redwire Space

Price: $23.70 | Mkt Cap: $4.71B | 52w Range: $4.87 — $24.92

Revenue (TTM): $371.0M | Rev Growth (TTM): +57.9% | Gross Margin: 12.9%

P/S Ratio: 12.7x | Analyst Target: $14.44 (-39.1% from current — major flag) | Rec: Strong Buy (but targets are all below price)

EBITDA: -$178.4M | Short Interest: 18.0%

Why It's In The Top 10:

Redwire is an in-space manufacturing and infrastructure company — solar arrays, space structures, ISS experiments, and spacecraft components. Revenue growing at 57.9% with multiple NASA and DoD contracts. The problem: the stock went from $4.87 to $24.92 — a 5x run — and EVERY analyst target is below current price. Highest target is $22, lowest is $7. The 18% short interest reflects real skepticism about valuation sustainability.

Key Catalysts:

• In-space manufacturing is a real long-term secular trend
• Multiple NASA commercial space station contracts (successor to ISS)
• 57.9% revenue growth suggests contract momentum is genuine
• Potential acquisition target given growing space M&A activity

Key Risks:

• ⚠️ ALL 10 analyst price targets are BELOW current price. This is a major red flag.
• 18% short interest — second highest on this space list
• EBITDA -$178.4M on $371M revenue = burning cash aggressively
• Gross margins of 12.9% are thin for a "tech" company — more like an engineering services shop
• Stock at 52w high essentially — most momentum already captured

Apex Verdict: The most contrarian pick on this list — the stock has run FAR ahead of analyst models. High risk. If you're already in, trail your stop. If you're looking to enter, wait for the pullback the shorts are betting on ($15-16 range), then reassess. The thesis is real but the price is not.

#10 — SATL: Satellogic

Price: $9.96 | Mkt Cap: $1.48B | 52w Range: $1.26 — $12.00

Revenue (TTM): $20.4M | Rev Growth (TTM): +80.3% | Gross Margin: 75.1%

P/S Ratio: 72.3x | Analyst Target: $9.58 (-3.8% from current) | Rec: Strong Buy (4/5 analysts)

EBITDA: -$21.4M | Short Interest: 9.4%

Why It's In The Top 10:

Satellogic is the emerging-market Earth observation play with a twist: they build ultra-low-cost satellites in Uruguay, then sell sub-meter resolution imagery at a fraction of what Planet Labs charges. 80.3% revenue growth from small base, 75% gross margins (best on this list by far), and a rebuilt analyst base (5 analysts, 4 strong buy) following a strategic reset. Analyst targets just raised across the board (Cantor: $10, Craig-Hallum: $10, Roth MKM: $10) — close to current price but sentiment improving.

Key Catalysts:

• Near-term government contracts from LatAm and Middle East defense customers
• US defense interest in non-US satellite imagery for redundancy
• 75% gross margins mean strong operating leverage as revenue scales
• Most recently: Cantor Fitzgerald raised target to $10 (May 13, 2026)

Key Risks:

• Revenue still tiny at $20.4M — needs 10x growth before this is a real business
• No EBITDA path visible in near term
• Thin analyst coverage (5 analysts) — liquidity risk
• Trading near its analyst target ($9.58) — limited analytical upside

Apex Verdict: Micro-cap lottery ticket with real technology, improving sentiment, and strong margins. For Bill: small position only (1-2% of portfolio max), buy pullbacks into $8-9 range. If revenue jumps, this re-rates dramatically.

🚁 US DRONE STOCKS — TOP 10 FOR 2026

#1 — AVAV: AeroVironment

Price: $202.35 | Mkt Cap: $10.2B | 52w Range: $156.00 — $417.86

Revenue (TTM): $1.61B | Rev Growth (TTM): +143.4% (includes BlueHalo acquisition) | Gross Margin: 25.0%

P/S Ratio: 6.4x | Analyst Target: $309.88 (+53.7% upside) | Rec: Buy (14 Buy, 2 Hold — 16 analysts)

EBITDA: $151.2M | Short Interest: 12.1%

Why It's In The Top 10:

AeroVironment is the best-positioned public drone company in the world right now. They make Switchblade loitering munitions (used in Ukraine — proven in combat), Puma, Raven, JUMP20, and acquired BlueHalo for high-energy laser systems in Dec 2023. The combined entity now has ~$1.93B in FY2026 revenue forecast (consensus), EBITDA positive, and 14 of 16 analysts saying buy with a $309 target vs current $202. The stock is down 52% from its 52w high of $417 — creating a rare setup where a fundamentally strong company is cheap on both an absolute and relative basis.

Key Catalysts:

• May 26, 2026: Expanding Huntsville facility to accelerate Freedom Eagle-1 Interceptor production
• May 12, 2026: $43M DoW Contract for PANTHER Phased Array antenna on SkyRange platforms
• LOCUST swarm demonstration at White Sands (May 6, 2026) with JIATF-401 — multi-drone autonomy
• MAYHEM 10 battlefield platform launched — autonomous ISR + strike capability
• FY2026 revenue forecast $1.93B (135% growth) → FY2027 $2.24B
• Up 11% TODAY (May 28, 2026) — momentum returning

Key Risks:

• 12.1% short interest — significant skeptic community arguing BlueHalo integration is dilutive
• Revenue growth driven partly by acquisition (BlueHalo) — organic growth rate is lower
• Down 52% from peak suggests the prior multiple was unsustainable
• Ukraine war wind-down would reduce Switchblade demand

Apex Verdict: Highest conviction drone pick on this list. Best fundamentals, best analyst consensus (+53.7% upside), EBITDA positive, and a 52%-off-peak price tag. If AVAV gets back to $300, that's a clean double from current. Bill: this is a size-up trade, not a lottery ticket.

#2 — AXON: Axon Enterprise

Price: $396.02 | Mkt Cap: $31.9B | 52w Range: $339.01 — $885.92

Revenue (TTM): $2.98B | Rev Growth (TTM): +33.7% | Gross Margin: 59.5%

P/S Ratio: 10.7x | Analyst Target: $662.04 (+67.2% upside) | Rec: Buy (18 Buy, 2 Hold — 20 analysts)

EBITDA: $102.9M | Short Interest: 4.9%

Why It's In The Top 10:

Axon is body cameras, Tasers, AI evidence management — and increasingly, drones as first responders. Their Axon Air program deploys drones before police arrive on scene. At $396 vs analyst target of $662, this stock has been absolutely destroyed from its $885 peak (down 55%). Why? FTC scrutiny on their Fusus acquisition and market concerns about police budget cycles. But the 33.7% revenue growth, 59.5% gross margins, and 10 strong buy ratings tell a different story. This is a high-quality growth compounder that got sold down hard.

Key Catalysts:

• Axon Air drone-as-first-responder program scaling to more US cities
• TASER 10 + Body Cam 4 upgrade cycles driving hardware revenue
• AI-powered evidence management (Draft One, Auto-Tagging) = sticky SaaS revenue
• 67.2% upside to analyst consensus target — best upside on this list for a large-cap
• Barclays (May 8), Morgan Stanley (May 7), BofA (May 7) all maintaining buy above current

Key Risks:

• FTC scrutiny on Fusus acquisition (surveillance concerns) could delay or block integration
• Highest P/E on the drone list at 160x trailing earnings — expensive even at $396
• Police/municipal budget cuts in a fiscal tightening environment
• Down 55% from 52w peak — momentum traders burned, selling pressure could continue

Apex Verdict: Recovery buy with the best risk/reward ratio among large-cap drone names. The FTC overhang created a massive gap between fundamentals and price. When FTC concern resolves (or fails to materialize), this stock snaps back hard. Bill: buy the dip aggressively under $400 — this is a layup at $662 price target.

#3 — KTOS: Kratos Defense & Security Solutions

(Full profile in Space section above)

Price: $64.09 | Mkt Cap: $12.0B | Analyst Target: $113.05 (+76.4% upside) | Rec: Buy

Why It's In Both Lists:

Kratos sits at the intersection of space launch (rocket propulsion) and drone warfare (XQ-58A Valkyrie, UTAP-22, autonomous combat systems). The Valkyrie is the DoD's primary affordable attritable UAV program. With 22.6% revenue growth, 20 analysts covering, and 76% upside to consensus target — KTOS is the highest-conviction value play across BOTH sectors on this report.

Key Catalysts (Drone-Specific):

• XQ-58A Valkyrie Collaborative Combat Aircraft selection ongoing — could unlock $500M+ in orders
• USAF Skyborg program integration
• DoD FY2026 defense authorization prioritizes low-cost attritable UAV programs
• Revenue forecast $1.78B (FY2026) growing to $2.2B (FY2027) as drone contracts convert

Apex Verdict: Top 3 pick across both lists. Buy every dip. 76% to analyst target is the best upside on a profitable defense name.

#4 — RCAT: Red Cat Holdings

Price: $12.38 | Mkt Cap: $1.88B | 52w Range: $5.71 — $18.78

Revenue (TTM): $54.6M | Rev Growth (TTM): +849.1% (from $5.7M base via Teal Drones acquisition) | Gross Margin: 7.5%

P/S Ratio: 34.5x | Analyst Target: $21.75 (+80.1% upside) | Rec: Strong Buy (all 4 analysts)

EBITDA: -$78.9M | Short Interest: 21.0% ⚠️

Why It's In The Top 10:

Red Cat Holdings acquired Teal Drones — one of the few US-made, DoD-approved small military drones (Blue UAS compliant). With Ukraine driving demand for battlefield ISR drones and the Pentagon mandating US-made alternatives to DJI, Red Cat is positioned as a core supplier. H.C. Wainwright just initiated with a Buy and $20 target on May 27, 2026 (yesterday). All 4 analysts say strong buy with a consensus target of $21.75 — 80% above current.

Key Catalysts:

• H.C. Wainwright Buy initiation at $20 (May 27, 2026)
• NDAA Section 848 banning DJI drones in federal use — accelerates demand for US alternatives
• Teal Golden Eagle drone selected for Army and Air Force programs
• FY2026 revenue ramp as military contracts scale
• Small position for Bill, but 80% analyst upside is the best risk-adjusted drone bet

Key Risks:

• ⚠️ 21% short interest — HIGHEST on this entire report. Shorts are aggressive here.
• Gross margins of 7.5% are terrible — they're essentially a hardware assembler, not a software-enabled drone business
• Still burning cash (-$78.9M EBITDA on $54.6M revenue)
• Revenue growth from tiny base — real scale TBD

Apex Verdict: Speculative play with elite analyst conviction. 80% upside to target, but 21% short interest means volatility will be extreme. For Bill: trade the swings, don't sleep on it. Size it small and respect the shorts.

#5 — ACHR: Archer Aviation

Price: $6.48 | Mkt Cap: $4.94B | 52w Range: $4.80 — $14.62

Revenue (TTM): $1.9M | Rev Growth (TTM): N/A (pre-revenue) | Gross Margin: 15.8%

P/S Ratio: 2,601x (meaningless — pre-revenue) | Analyst Target: $10.61 (+60.0% upside) | Rec: Buy (6 Buy, 3 Hold)

EBITDA: -$813.9M | Short Interest: 16.2%

Why It's In The Top 10:

Archer is building the Midnight eVTOL aircraft — an electric air taxi targeting 60-mile urban routes. They have a $1B+ order from United Airlines and a manufacturing partnership with Stellantis. The stock fell 56% from its 52w high of $14.62 to current $6.48 — but analyst consensus is $10.61 (+60%). The FAA certification pathway is real (they're progressing through Part 135 certification), and the DoD signed a contract for Midnight deployment in military scenarios.

Key Catalysts:

• FAA Type Certificate progress — each milestone is a major re-rate catalyst
• United Airlines order backlog ($1B+)
• DoD/AFWERX contract for military Midnight deployment
• 60% upside to analyst target at current depressed price
• Stellantis manufacturing partnership means they won't be supply-chain constrained

Key Risks:

• Essentially zero revenue ($1.9M) — this is a certification bet
• EBITDA burn of -$813.9M is enormous for a $4.9B company
• 16.2% short interest
• FAA certification delays have plagued every eVTOL company
• Goldman maintains Hold at $9 — not everyone is convinced

Apex Verdict: Speculative eVTOL bet with more momentum than Joby at a lower valuation. If FAA certification happens in 2026-2027, this is a 3-5x stock. If it slips to 2028+, holders get diluted. For Bill: this is a dated-event play — track FAA milestones, not fundamentals.

#6 — JOBY: Joby Aviation

Price: $11.38 | Mkt Cap: $11.2B | 52w Range: $7.34 — $20.95

Revenue (TTM): $77.7M | Rev Growth (TTM): N/A | Gross Margin: 38.0%

P/S Ratio: 144.1x | Analyst Target: $11.12 (-2.3% from current) | Rec: Hold

EBITDA: -$747.9M | Short Interest: 12.97%

Why It's In The Top 10:

Joby has the deepest funding ($2.7B raised), Toyota backing, and the most advanced FAA certification path in the eVTOL space. They're targeting commercial launch in Dubai 2025-2026 and US commercial ops in 2026. The DoD contract is active. At $11.38 with analyst target at $11.12 — the market has essentially said "fair value here" and the Hold consensus reflects genuine uncertainty about timing.

Key Catalysts:

• Dubai commercial launch could serve as the proof-of-concept moment that re-rates the entire sector
• Toyota strategic investment ($894M) provides production credibility
• H.C. Wainwright maintains Buy at $18 — most bullish analyst sees 58% upside
• FAA Part 135 air carrier certificate progress

Key Risks:

• Goldman Sachs downgraded to Sell at $9 (May 11, 2026) — the bear case is loud
• EBITDA burn of -$748M is punishing
• Hold consensus at virtually no upside to target means the market is not impressed
• 13% short interest
• Valuation at $11.2B market cap with $78M revenue is entirely a certification optionality bet

Apex Verdict: Joby is the safer eVTOL bet (bigger, better funded) but with LESS near-term upside than ACHR. Consensus says "hold" and price reflects fair value. If Dubai launch succeeds publicly, this re-rates 50%+. Watch from the sidelines unless there's a clear FAA or commercial catalyst.

#7 — DPRO: Draganfly

Price: $7.47 | Mkt Cap: $272.6M | 52w Range: $1.69 — $14.40

Revenue (TTM): $8.5M | Rev Growth (TTM): +49.4% | Gross Margin: -0.4% (negative — below COGS)

P/S Ratio: 32.1x | Analyst Target: $12.74 (+68.1% upside) | Rec: Strong Buy (6 analysts)

EBITDA: -$24.6M | Short Interest: 11.8%

Why It's In The Top 10:

Draganfly makes commercial drones for emergency services, agriculture, healthcare delivery, and defense. Revenue growing at 49% but from a very small base. 6 analysts, all strong buy, with $12.74 consensus target = 68% upside. Up 3x from 52w low. The story is real: Draganfly has drone-as-medical-delivery contracts, first-responder contracts, and has been expanding into both US military and commercial markets.

Key Catalysts:

• Northland Securities initiated Buy at $13 (May 19, 2026)
• Healthcare drone delivery contracts expanding (unique niche)
• Canadian and US first responder deployments growing
• Revenue growing 49% from $5.7M to $8.5M — needs to hit $15-20M to be real

Key Risks:

• Negative gross margins — they are LOSING money on every unit sold currently
• Tiny market cap ($273M) — liquidity risk for larger positions
• Highly dilutive capital raises likely to fund growth
• Very small revenue base — any miss = 30-40% selloff

Apex Verdict: High-risk, high-reward micro-cap speculative play. 68% to analyst target but the negative gross margin is a real problem. For Bill: tiny position only (0.5-1%), buy on pullbacks to $6-6.50. Expect extreme volatility.

#8 — RTX: RTX Corporation (Counter-Drone + UAS Division)

(Full profile in Space section)

Price: $176.97 | Mkt Cap: $238.3B | Analyst Target: $215.27 (+21.6% upside) | Rec: Buy

Drone-Specific Thesis:

RTX's Raytheon division is the leader in counter-drone systems (Coyote Block 3 interceptor, Ku720 ground radar). As drone warfare proliferates, counter-drone spending is growing faster than offensive drone spending. RTX is playing BOTH sides — making precision munitions that destroy drones AND the interceptor systems that defend against them. At 22% upside to consensus target, RTX is the safest way to get drone exposure in the sector.

Apex Verdict: Defensive drone pick for the portion of the portfolio that doesn't need to double. Buy the dips — you own both the attack and the shield.

#9 — LMT: Lockheed Martin

Price: $532.75 | Mkt Cap: $122.8B | 52w Range: $410.11 — $692.00

Revenue (TTM): $75.1B | Rev Growth (TTM): +0.3% | Gross Margin: 9.9%

P/S Ratio: 1.64x | Analyst Target: $625.16 (+17.3% upside) | Rec: Hold (consensus)

EBITDA: $8.0B | Short Interest: 1.3%

Why It's In The Top 10:

Lockheed makes the F-35 (the platform that shoots down drones), Skunkworks autonomous systems (SR-72, various classified UAVs), and has a growing drone portfolio including Indago quadrotor and VIRUS loitering munition concepts. With 17% upside to target at $625 and a Hold consensus, this is the "defensive value" drone name. Revenue growth is flat at 0.3% — but the stock is down 23% from 52w high of $692, and at P/S of 1.64x it's objectively cheap for a defense prime.

Key Catalysts:

• F-35 production ramp and international orders (Finland, Germany, Belgium) accelerating
• Classified drone/autonomous systems programs (Skunkworks)
• DoD budget increases directionally positive for all defense primes

Key Risks:

• 0.3% revenue growth is essentially flat — this is not a growth story
• Hold consensus means analyst community sees limited near-term upside
• F-35 cost overruns are a perennial source of headlines

Apex Verdict: Deep value defense name with limited near-term excitement. Buy at $500-510 support zone for a $620+ target. Boring but works. Not a swing trade — a parking spot.

#10 — GD: General Dynamics

Price: $343.84 | Mkt Cap: $93.0B | 52w Range: $268.10 — $369.70

Revenue (TTM): $53.8B | Rev Growth (TTM): +10.3% | Gross Margin: 15.2%

P/S Ratio: 1.73x | Analyst Target: $392.22 (+14.1% upside) | Rec: Buy

EBITDA: $6.49B | Short Interest: 1.2%

Why It's In The Top 10:

General Dynamics' Mission Systems division produces the Bluefin autonomous underwater vehicles (AUVs) and the Abrams unmanned logistics support systems. 10.3% revenue growth is among the strongest of the defense primes. Gulfstream business jet demand is at record levels (luxury resilient). At 1.73x P/S with 14.1% upside to target, GD is solid but not exciting. Worth owning for the drone/autonomous systems exposure within a profitable, diversified defense platform.

Key Catalysts:

• Gulfstream G700/G800 order book near-record
• Mission Systems autonomous vehicle contracts growing
• Revenue growth at 10.3% — best of the big three defense primes (LMT: 0.3%, NOC: 4.4%)

Key Risks:

• Bluefin AUV/autonomous systems is a small fraction of total revenue
• Limited pure-play drone exposure — mostly defense diversified

Apex Verdict: Quality over excitement. Buy dips toward $320 for $392 target. 14.1% upside + dividend = decent risk-adjusted return. For Bill: this is a core defensive position, not where you put capital for big moves.

📊 QUICK COMPARISON TABLES

Space Stocks

Drone Stocks

⚠️ = Currently trading above analyst consensus target | ✅ = Strong upside to analyst target

🧠 APEX SYNTHESIS

🚀 Space — The State of the Sector

• We are in early-innings of the commercialization cycle, not the speculative bubble. Revenue is real at RKLB, ASTS, PL, BWXT, KTOS. This isn't 2021 SPAC nonsense — these companies have contracts, launches, and paying customers. The narrative has shifted from "can they survive?" to "how big will they get?"

• The highest-conviction plays in space are paradoxically the boring ones. BWXT (nuclear propulsion, Navy contracts, 20% to target) and NOC (26% to target, $7.3B EBITDA) offer the best risk-adjusted returns in the sector. RKLB, ASTS, and PL are momentum/narrative plays that have already massively outperformed their analyst models — proceed with extreme caution at current prices.

• The defense budget supercycle is the real macro tailwind. Every NATO country is ratcheting up defense spending. Space-based ISR, missile defense (RTX/NOC), and drone warfare are the three fastest-growing line items in every major defense budget. This creates a decade-long tailwind that doesn't depend on any single commercial customer.

• Watch for: Neutron rocket first launch (RKLB), ASTS BlueBird subscriber numbers, and any KTOS contract awards. These are the three most market-moving events in space stocks for the back half of 2026.

🚁 Drones — The State of the Sector

• The military drone market is the real story in 2026, not consumer or commercial. Ukraine proved the tactical value of low-cost attritable drones. Every military is now buying them. AVAV, KTOS, and RCAT are the three publicly-traded pure-plays on this trend. AVAV is by far the best-positioned with real revenue, real profits, and a $310 analyst target.

• eVTOL (JOBY, ACHR) is a certification game, not a revenue game. Both companies have essentially zero commercial revenue. The entire thesis rides on FAA certification timelines. Trade them as binary event plays — buy before milestone announcements, sell the news. Don't hold through six months of silence.

• AXON is the sleeper pick on the drone list. Most people think "tasers and body cams." But Axon Air (drone-as-first-responder) is becoming a mandatory procurement item for major police departments. 33.7% revenue growth, 59.5% gross margins, 20 analysts on Buy, and 67% upside to consensus while the stock sits 55% off its 52w high. This is a swing trader's dream setup.

• Beware the delisted/dying drone names. SKYD (delisted), LILM (bankrupt/relisted overseas), UAVS (dying revenue, zero analyst coverage), AEYE (not even a drone company). The list was full of traps — the universe was aggressively pruned.

🏆 TOP 3 HIGHEST CONVICTION PICKS — ACROSS BOTH SECTORS

🥇 #1 — KTOS (Kratos Defense & Security Solutions)

Price: $64.09 | Target: $113.05 | Upside: +76.4%

The single best risk/reward setup on this entire report. Profitable. Growing at 22%+. 20 analyst coverage, 12 strong buy. Makes both loyal wingman drones (XQ-58A Valkyrie) AND rocket propulsion for space — dual exposure to the two hottest defense spending categories. Down 52% from 52w high but the thesis is intact. Revenue forecast $1.78B this year, $2.2B next year. When this stock gets its next contract announcement, it bounces hard. Buy everything under $70.

🥈 #2 — AVAV (AeroVironment)

Price: $202.35 | Target: $309.88 | Upside: +53.7%

Best fundamentals in the drone sector. EBITDA positive. 143% TTM revenue growth (partially acquisition-driven, but still impressive). Up 11% today as the market wakes up. Multiple contracts awarded in 2026. Analyst community is almost uniformly bullish (14/16 buy). Down 52% from peak = opportunity. The Freedom Eagle-1 Interceptor expansion (Huntsville, May 26) shows production acceleration. A $300 stock at $202 is just value. Size up on dips under $195.

🥉 #3 — AXON (Axon Enterprise)

Price: $396.02 | Target: $662.04 | Upside: +67.2%

The best-quality business on this entire list (59.5% gross margins, $3B revenue, 33.7% growth). Drone-as-first-responder is an underappreciated secular growth driver. 20 analysts covering, 18 with buy/strong buy. J.P. Morgan target: $755. BofA: $700. The FTC concern created a gift: a 55% discount from $885 peak. This stock doesn't need to recover to ATH to be a winner — just getting to $550 is a 38% gain from here. This is the swing trader's favorite setup: quality on sale.

Report compiled May 28, 2026. All prices as of market open. Data sourced from yfinance (live), stockanalysis.com, and company investor pages. This is research, not financial advice. Past performance of sectors does not guarantee future results. Bill, you're up 68% YTD — be selective and size correctly.

Data Verification Notes:

• SKYD, VORB, ASTR: Confirmed delisted (no data returned from yfinance)
• AEYE confirmed as AudioEye (accessibility software) — incorrectly suggested as drone stock; excluded
• AVAV revenue growth of 143% includes BlueHalo acquisition (Dec 2023) — organic growth ~14.5% per FY2025 annual; TTM figure reflects acquisition boost
• ASTS revenue growth of 1,952% = $4.1M → $84.9M TTM; FY2025 full-year growth was 153.5%
• RCAT revenue growth of 849% from Teal Drones acquisition; small absolute base ($5.7M → $54.6M)
• All analyst targets from S&P Global via stockanalysis.com, fetched May 28, 2026